stockrowBGM Group Ltd.
BGM Healthcare Drug Manufacturers Specialty & Generic
BGM Group Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $37.9 million, up 51.1% from fiscal 2024.
Follow BGM
Alert me
BGM Group Ltd. (BGM) EV/Sales
As of 5 November 2026, BGM Group Ltd. (BGM) trades at a EV/Sales of −0.1×. Over the past ten years it has ranged from −0.2× (September 2024) to 0.0× (September 2022); the current reading is higher than 53% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.9× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | −0.1× | — |
| FY2024 | −0.1× | — |
| FY2023 | −0.2× | — |
| FY2022 | −0.1× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Mar 2023 | 1.8× | 13.18% |
| Sep 2022 | 1.6× | — |
| Mar 2022 | 0.0× | — |
| Sep 2021 | 0.0× | — |
| 1 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BGM BGM Group Ltd. | −0.1× |
| CRDL Cardiol Therapeutics Inc. compare | n/m |
| AKBA Akebia Therapeutics, Inc. compare | 0.1× |
| ORGO Organogenesis compare | 0.3× |
| OGI Organigram Global Inc. compare | 0.6× |
| GLAS Glass House Brands Inc. compare | 1.4× |
| DERM Journey Medical Corporation compare | 1.7× |
| ADCT ADC Therapeutics SA compare | 1.9× |
| SIGA Siga Technologies Inc. compare | 4.7× |
| Drug Manufacturers Specialty & Generic industry median | 2.9× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)